Andrew Booth - Dec 10, 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Financial Officer
Signature
/s/ Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Dec 10, 2021
Transactions value $
$160,000
Form type
4
Date filed
12/10/2021, 04:00 PM
Previous filing
Dec 9, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Options Exercise $160K +500K +934.58% $0.32* 554K Dec 10, 2021 Direct
holding ABCL Common Shares 131K Dec 10, 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share Options (right to buy) Options Exercise $0 -500K -8.5% $0.00 5.38M Dec 10, 2021 Common Shares 500K $0.32 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.